Precision Biosciences DTIL
NASDAQ DTIL
$6.78 +0.07 (+1.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Long-Term Debt Issuances (2019 - 2024)

Updated

Precision Biosciences (DTIL) recorded Long-Term Debt Issuances of -$20,000 in fiscal Q4 2024 (quarter ended Dec 31, 2024).

Analysis

Precision Biosciences (DTIL) Long-Term Debt Issuances (2019 - 2024) Analysis & Trends

For FY2024 (ended Dec 31, 2024), Precision Biosciences reported Long-Term Debt Issuances of $22.47 million.

  • Annual Long-Term Debt Issuances has a five-year compound annual growth rate of -10.7% (FY2019 to FY2024).
  • Across earlier fiscal years, Long-Term Debt Issuances came in at $19.81 million in FY2022 (+690.6%) and $2.51 million in FY2021.
  • The fiscal Q4 2024 figure is the highest quarterly Long-Term Debt Issuances since fiscal Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Precision Biosciences 174.27 Mn -174.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -20,000.00
Dec 31, 2022 -5,000.00
Sep 30, 2022 -160,000.00
Dec 31, 2021 2.51 Mn
Sep 30, 2021 -5,000.00
Mar 31, 2019 39.55 Mn
API Access

Precision Biosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=DTIL&period=max&api_key=YOUR_API_KEY